FDA Inspection 1178701 — St. Agnes Medical Center IRB

St. Agnes Medical Center IRB — FEI 3008553935

The FDA completed an inspection of St. Agnes Medical Center IRB on Sep 1, 2022 in Fresno, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 1, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Fresno, CA (United States)

Additional Details

IRB

Citations

IDCFRDescription
296621 CFR 812.66No IRB notification of significant risk determination
731821 CFR 56.115(a)(2)Minutes of IRB meetings
733421 CFR 56.115(a)(5)List of members
733721 CFR 56.115(b)Retention of records
769021 CFR 56.106(c)Renewal every 3 years
769321 CFR 56.106(e)Changes re: review new products or discontinue reviewing